Exodus Point Capital Management, LP Generation Bio Co. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding GBIO
# of Institutions
80Shares Held
50MCall Options Held
100Put Options Held
200-
Price T Rowe Associates Inc Baltimore, MD9.51MShares$23.5 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC8.28MShares$20.5 Million3.11% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.92MShares$9.68 Million0.18% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$8.14 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.98MShares$7.36 Million0.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $146M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...